Getinge AB Class B GNGBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GNGBF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $17.50
- Day Range
- $20.00–20.00
- 52-Week Range
- $17.09–22.39
- Bid/Ask
- $18.55 / $20.26
- Market Cap
- $5.45 Bil
- Volume/Avg
- 200 / 3,886
Key Statistics
- Price/Earnings (Normalized)
- 21.38
- Price/Sales
- 1.74
- Dividend Yield (Trailing)
- 2.01%
- Dividend Yield (Forward)
- 2.01%
- Total Yield
- 2.01%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,891
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GNGBF
|
TFX
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.38 | 16.13 | 15.11 |
Price/Book Value | 1.84 | 2.30 | 2.06 |
Price/Sales | 1.74 | 3.47 | 3.23 |
Price/Cash Flow | 11.18 | 16.04 | 14.40 |
Price/Earnings
GNGBF
TFX
MDT
Financial Strength
|
Metric
|
GNGBF
|
TFX
|
MDT
|
|---|---|---|---|
Quick Ratio | 0.65 | 1.20 | 1.31 |
Current Ratio | 1.15 | 2.51 | 2.03 |
Interest Coverage | 9.07 | 4.32 | 7.73 |
Quick Ratio
GNGBF
TFX
MDT
Profitability
|
Metric
|
GNGBF
|
TFX
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 5.02% | 5.24% | 7.64% |
Return on Equity (Normalized) | 8.70% | 8.81% | 13.51% |
Return on Invested Capital (Normalized) | 7.75% | 7.31% | 9.78% |
Return on Assets
GNGBF
TFX
MDT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Kmzczhj | Dqtbns | $183.1 Bil | |||
| Stryker Corp
SYK
| Ymcrrmcjz | Qfrph | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Zjzlvhxhj | Lnxcnjx | $110.1 Bil | |||
| Medtronic PLC
MDT
| Zflbyhb | Sytxkg | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Nmxpmkjfq | Xzywn | $37.6 Bil | |||
| DexCom Inc
DXCM
| Nhtdkzbsv | Rybsh | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Rvdmwlg | Mgmxpc | $24.1 Bil | |||
| Steris PLC
STE
| Zzlzkffd | Vyfnk | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Zkhgntjfx | Vlx | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Dhsnjntx | Mcsjzr | $16.6 Bil |